|
Jul 02, 2020
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
|
Jun 10, 2020
|
Galidesivir Stops Zika Viral Replication in Primate Model
|
|
|
Jun 09, 2020
|
BioCryst Announces Berotralstat Expanded Access Program for Patients with Hereditary Angioedema in United States
|
|
|
Jun 06, 2020
|
Hereditary Angioedema Patients Report Breakthrough Attacks on Current Injectable/Infused Prophylaxis Medication
|
|
|
Jun 06, 2020
|
Long-term (48-week) Data Show Treatment with Berotralstat Provides Robust and Durable Reductions in HAE Attacks and Improvements in Quality of Life Scores
|
|
|
Jun 02, 2020
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
|
Jun 01, 2020
|
BioCryst Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Completion of Public Offering of Common Stock and Pre-Funded Warrants
|
|
|
May 28, 2020
|
BioCryst to Present at Jefferies Virtual Healthcare Conference
|
|
|
May 27, 2020
|
BioCryst Prices Public Offering of Common Stock and Pre-Funded Warrants
|
|
|
May 27, 2020
|
BioCryst Commences Public Offering of Common Stock and Pre-Funded Warrants
|
|
